Expertise in
2
conditions

Weili Pan

No. 158, Shangtang Road, 
Hangzhou, CN 
Expertise in
2
conditions
No. 158, Shangtang Road, 
Hangzhou, CN 

Overview

Weili Pan practices practicing medicine in Hangzhou, China.

Pan is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Plaque Psoriasis, Psoriasis, Candida Infection of the Skin, and Melasma.

They are actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials.

Locations

No. 158, Shangtang Road, Hangzhou, 310014, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: April 07, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period to Evaluate the Efficacy and Safety of LY2439821 in Chinese Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: June 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

15 Total Publications

Immune cell phenotypes in the context of diabetic nephropathy: A Mendelian randomization analysis.
Immune cell phenotypes in the context of diabetic nephropathy: A Mendelian randomization analysis.
Journal: Medicine
Published: December 31, 2025

Frequently Asked Questions about Weili Pan

Is Weili Pan a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Weili Pan is classified as an Distinguished expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Weili Pan participate in research or clinical trials?

Yes. Weili Pan has published 15 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Weili Pan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pan's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile